Ventana Image Analysis System - Pathway HER2 (4B5)
510(k) K061613
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK061613 | Date10 Jan 2007 | StatusActive |
Recalls
-
- Terminated Z-0571-2008
Incomplete upgrade: The software upgrade from February 1, 2007 may not have been completed. This software upgrade adds the algorithm (Slidetype) for the PATHWAY anti-HER-2/neu (4B5) antibody to the VIAS system.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- NQN
- Device Class
- Class II
- Regulation
- 21 CFR Part 864.1860
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Ventana Image Analysis System - Pathway Her2 (4B5) is an automated, operator-intervention microscope designed for immunohistochemistry (IHC) image analysis. It quantifies nuclear intensity and percent positivity of HER2/neu expression in tissue samples using digital imaging and specialized software. This system supports diagnostic assessment in hematology, particularly for evaluating HER2 status in breast cancer pathology. As a Class II medical device, it integrates microscopy, digital capture, and algorithmic analysis to assist pathologists in standardized HER2 scoring.
This system is supplied as a standalone device for laboratory use, requiring operator intervention to select and analyze slides stained with the VENTANA anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody. It operates in non-sterile settings and is intended for single-use per slide analysis, though the hardware itself may be reusable across multiple procedures. The device complies with FDA 510(k) clearance (K061613) under the Hematology advisory committee, with no specific MRI safety restrictions noted. Storage and handling follow standard laboratory protocols for automated IHC analysis equipment.
Other devices from Tripath Imaging, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the Ventana Image Analysis System - Pathway HER2 (4B5) used for?
This system is designed for immunohistochemistry (IHC) image analysis to quantify nuclear intensity and percent positivity of HER2/neu expression in tissue samples. It assists pathologists in evaluating HER2 status, particularly in breast cancer diagnostics, by providing standardized scoring through automated digital imaging and specialized software.
How is the Ventana Image Analysis System - Pathway HER2 (4B5) supplied and intended for use?
The device is supplied as a standalone unit for laboratory use and requires operator intervention to select and analyze slides. It is intended for single-use per slide analysis when paired with the VENTANA anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody. The hardware itself is reusable across multiple procedures, but each slide analysis is considered a single-use event.
Is the Ventana Image Analysis System - Pathway HER2 (4B5) sterile, and where should it be used?
The system is not sterile and is designed for use in non-sterile laboratory settings. It adheres to standard laboratory protocols for automated immunohistochemistry (IHC) analysis equipment, ensuring proper handling and maintenance in a controlled diagnostic environment.
Can the Ventana Image Analysis System - Pathway HER2 (4B5) be reused for multiple procedures?
The hardware of the Ventana Image Analysis System is reusable across multiple procedures, but each slide analysis is intended for single-use. This means the device itself can be used repeatedly, but the analysis of individual slides follows a single-use protocol to maintain accuracy and reliability.
What regulatory clearance does the Ventana Image Analysis System - Pathway HER2 (4B5) hold?
The device holds FDA 510(k) clearance (K061613) under the Hematology advisory committee, classified as substantially equivalent to existing devices. This clearance was granted in 2007, confirming its compliance with regulatory standards for automated microscopy and image analysis in hematology diagnostics.